ソマトスタチン-14
- ¥40000 - ¥355500
- 化學(xué)名: ソマトスタチン-14
- 英語名: Somatostatin
- 別名:
- CAS番號: 51110-01-1
- 分子式: C76H104N18O19S2
- 分子量: 1637.88
- EINECS:256-969-7
- MDL Number:MFCD00076762
4物価
選択條件:
ブランド
- 富士フイルム和光純薬株式會社(wako)
パッケージ
- 1mg
- 5mg
- 10mg
- 25mg
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01TOC1157
- 製品説明
- 英語製品説明Somatostatin
- 包裝単位1mg
- 価格¥40000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01LKTS5749
- 製品説明ソマトスタチン-14
- 英語製品説明Somatostatin-14
- 包裝単位5mg
- 価格¥96300
- 更新しました2023-06-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01LKTS5749
- 製品説明ソマトスタチン-14
- 英語製品説明Somatostatin-14
- 包裝単位10mg
- 価格¥177700
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01LKTS5749
- 製品説明ソマトスタチン-14
- 英語製品説明Somatostatin-14
- 包裝単位25mg
- 価格¥355500
- 更新しました2024-03-01
- 購入
生産者 | 製品番號 | 製品説明 | 包裝単位 | 価格 | 更新時間 | 購入 |
---|---|---|---|---|---|---|
富士フイルム和光純薬株式會社(wako) | W01TOC1157 | Somatostatin |
1mg | ¥40000 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01LKTS5749 | ソマトスタチン-14 Somatostatin-14 |
5mg | ¥96300 | 2023-06-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01LKTS5749 | ソマトスタチン-14 Somatostatin-14 |
10mg | ¥177700 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01LKTS5749 | ソマトスタチン-14 Somatostatin-14 |
25mg | ¥355500 | 2024-03-01 | 購入 |
プロパティ
貯蔵溫度 :−20°C
溶解性 :H2O: 1 mg/mL
外見 :powder
水溶解度 :Soluble in water (0.3 mg/ml)
溶解性 :H2O: 1 mg/mL
外見 :powder
水溶解度 :Soluble in water (0.3 mg/ml)
安全情報
絵表示(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
注意喚起語: | ||||||||
危険有害性情報: |
|
|||||||
注意書き: |
|
説明
Originally isolated from hypothalamic tissue, somatostatin is characterized as an inhibitor of growth hormone (GH) release. The structure was determined in 1971. Subsequent investigations led to the recognition that somatostatin also was released from the pancreas and has a role of inhibiting the secretion of both insulin and glucagon. A total of five somatostatin receptor subtypes have been characterized and cloned (sst1 to sst5). Subtype sst4 is associated with the inhibition of insulin release, and an sst4-selective inhibitor has been reported. The somatostatin analogue SOM230 has exhibited selectivity for sst1, sst2, sst3, and sst5 in rats and effectively decreased plasma GH and insulin-like growth factor-1 (IGF-1) levels by 75% without significant effects on insulin or glucagon. Another analogue, PT R3173, with selectivity for recombinant human somatostatin receptor (hsst2, hsst4, hsst5) was substantially more effective in inhibiting GH secretion compared to glucagon and insulin release in rats.関連商品価格
- 成長ホルモン
¥57700-72700 - 成長ホルモン放出抑制ホルモン
¥9000-321000 - ソマトスタチン28
¥46400-174000
供給者とメーカー
Xinxiang Hongqi District Houyuan Trading Co.,Ltd
Hebei Xinsheng New Material Technology Co., LTD.
Dorne Chemical Technology co. LTD
Nantong Guangyuan Chemicl Co,Ltd
Shanghai Affida new material science and technology center
Hangzhou Hyper Chemicals Limited
hebei hongtan Biotechnology Co., Ltd
Shandong Huizhihan Supply Chain Co., Ltd
Alpha Biopharmaceuticals Co., Ltd
Henan Tianfu Chemical Co.,Ltd.